Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Atomo Diagnostics Ltd. ( (AU:AT1) ) has provided an update.
Atomo Diagnostics Ltd has appointed Mr. Patrick Cook as the Independent Chair of the Board, succeeding Mr. John Kelly, who will now focus on his role as Managing Director. Mr. Cook brings over 35 years of experience in the medical devices and point-of-care diagnostics sectors, and his leadership is expected to guide Atomo through its strategic objectives as decentralized testing gains prominence in the diagnostic market.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd is an Australian-headquartered medical device company specializing in unique, integrated rapid diagnostic test devices for the global diagnostic market. Their patented devices simplify testing procedures, enhance usability, and improve reliability for rapid point-of-care and at-home testing applications. The company has commercialized products internationally and has supply agreements for testing applications targeting infectious diseases such as HIV, Active Syphilis, viral vs bacterial differentiation, and early pregnancy detection.
Average Trading Volume: 1,715,465
Technical Sentiment Signal: Hold
Current Market Cap: A$15.39M
For a thorough assessment of AT1 stock, go to TipRanks’ Stock Analysis page.